(NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more than 30 years ...
Zacks Small Cap Research on MSN
OTC Markets hosts virtual investor presentation with Eric Schlorff, CEO of SeaStar Medical, and David Bautz, PhD, senior analyst at Zacks SCR
NASDAQ: ICU John Viglotti: Hello, and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we're very pleased you joined us for the first ...
Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...
Onboarding and mentoring new clinicians sets them up for success and boosts retention. In this episode of HL Shorts, find out about the best practices for onboarding and mentoring new clinicians from ...
A growing field of research suggests that some medical treatments, such as cancer therapy or vaccines, might be more ...
Morning Overview on MSN
Neuralink human trials: What the brain implant tests involve?
Neuralink’s first brain implant in a human patient took place in January 2024, but the details of what the company’s clinical trial actually requires of participants, regulators, and the company ...
Breakthrough manufacturing process comes in preparation for upcoming commercial launch in Europe planned for later this ...
ESTERO, FL / ACCESS Newswire / March 17, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire"), wholly owned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results